Cardio Conditions Flashcards

(245 cards)

1
Q

Describe the etiology/RF for hypertension

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the clinical presentation & PE for hypertension

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the range of BP from normal to stage 2 HTN

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe malignant HTN

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the non-pharm treatments for HTN

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the 4 main classes of first line antihypertensives

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the etiology & RFs for aortic aneurysm

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the clinical presentation of aortic aneurysm and aortic aneurysm rupture

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the PE for an aortic aneurysm

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the testing and screening procedures for aortic aneurysm and rupture

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the treatment for aortic aneurysm and rupture

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the etiology of aortic dissection

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the clinical presentation of aortic dissection

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the diagnostic testing for aortic dissection

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the treatment for aortic dissection

A

Stanford A = surgical

Stanford B = medical management
- BP control goal 100-120 systolic (BB, CCB, IV nitroprusside)
- arterial pressure, central venous pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are some contraindications to aortic dissection surgical repair

A

CVA, severe valve disease, recent MI, pregnancy, advanced age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Describe the etiology of rheumatic heart disease

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Describe the clinical presentation and PE of rheumatic heart disease

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Describe the diagnostic testing for rheumatic heart disease

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Describe the treatment for rheumatic heart disease

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Describe the etiology of mitral/tricuspid regurgitation

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Describe the clinical presentation of mitral/tricuspid regurgitation

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Describe the murmur heard in mitral and tricuspid regurgitation

A

Mitral best heard at apex, tricuspid best heard at LLSB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Describe the treatment for mitral/tricuspid regurgitation

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Describe the etiology of a mitral S3 gallop murmur
Diastolic Gallop sound in early diastole as a result of extra blood filling back into ventricle & splashing (every 3-4 beats)
26
Describe the mitral valve prolapse murmur
mid to late systolic click of the valve and late systolic murmur
27
Describe the etiology of aortic stenosis
28
Describe the clinical presentation of aortic stenosis
29
Describe the murmur heard in aortic stenosis
Auscultation: - ejection click following S1 best heard at left lower sternal border - systolic crescendo-decrescendo ejection murmur heard at URSB 2nd ICS that radiates to carotid arteries bilaterally
30
Describe the treatment for aortic stenosis
31
Describe the etiology of pulmonic stenosis
32
Describe the clinical presentation of pulmonic stenosis
33
Describe the murmur for pulmonic stenosis
34
Describe the etiology of mitral stenosis
35
Describe the clinical presentation of mitral stenosis
36
Describe the murmur for mitral stenosis
37
Describe the treatment for mitral stenosis
38
Describe the etiology of aortic regurgitation
39
Describe the clinical presentation of aortic regurgitation
dyspnea, PND, orthopnea
40
Describe the murmur heard in aortic regurgitation
Early diastolic decrescendo murmur, heard best at 3rd LICS, high pitch blowing, can include S3 sound
41
Describe the treatment for aortic regurgitation
42
Describe the etiology of an S4 atrial gallop
Diastolic murmur L atria contracting against a stenotic L ventricle, often a sign of diastolic HF
43
Describe the etiology of SVT
can be triggered by stimulants, alcohol, digoxin, MI, pericarditis, valvulopathy, PE, COPD
44
Describe the treatment for SVT
45
Describe the etiology of premature atrial contraction
46
Describe the etiology of premature ventricular contraction
47
Describe the clinical presentation of PAC and PVC
48
Describe the treatment for PVCs
beta blocker if symptomatic, to reduce frequency
49
Describe the etiology of wolff parkinson white syndrome
50
Describe the clinical presentation of WPW syndrome
51
Describe the treatment for WPW syndrome
52
Describe the etiology of idioventricular conduction delay
53
Describe the RFs for IV conduction delay
54
Describe the etiology of RBBB
55
Describe the EKG for RBBB
56
Describe the etiology of LBBB
57
Describe the EKG in LBBB
58
Describe the etiology of tachy/brady syndrome
59
Describe the clinical presentation of tachy/brady syndrome
60
Describe the etiology of v-tach
61
Describe the clinical presentation of V-tach
62
Describe the treatment for v-tach
63
Describe the etiology of v-fib
64
Describe the etiology of acute aortic stenosis
65
Describe the clinical presentation of acute aortic stenosis
66
Describe the treatment for acute aortic stenosis
67
Describe the etiology of long QT syndrome
68
Describe the etiology of a third degree AV block
69
Describe the clinical presentation of a third degree AV block
70
Describe the treatment for third degree AV block
71
Describe the etiology of a-fib with rapid ventricular response
sxs: palpitations, chest pain, pre/syncope, dyspnea
72
Describe the treatment for a-fib with rapid ventricular response
73
Describe the treatment for WPW syndrome
74
Describe the etiology & RFs for acute MI
75
Describe the clinical presentation of an acute MI
76
Describe the EKG findings for a STEMI vs NSTEMI
77
Describe the treatment for STEMI & NSTEMI and some complications
78
Describe the etiology of PE
79
Describe the diagnostic testing for PE
80
Describe the treatment for PE
81
Describe the etiology of cardiogenic shock
82
Describe the clinical presentation of cardiogenic shock
83
Describe the etiology of Kawasaki syndrome
84
Describe the clinical presentation of kawasaki syndrome
85
Describe the diagnostic testing for kawasaki syndrome
86
Describe the treatment for kawasaki syndrome
IVIG & ASA mainstay
87
Describe the EKG for hypokalemia
88
Describe the etiology of an anterior MI
89
describe De Winter T waves seen in anterior MI
90
Describe which leads show ischemia in septal, anterior, lateral, anteroseptal, anterolateral territories
91
Describe the etiology for a lateral STEMI
92
Describe the etiology for an inferior STEMI
93
Describe the EKG for an inferior STEMI
94
Describe the etiology of right ventricular infarction
95
Describe the etiology and EKG for posterior MI
96
Describe the etiology of subendocardial infarction
97
Describe the etiology of brugada syndrome
98
Describe the EKG for brugada syndrome
99
Describe the etiology of takotsubo cardiomyopathy & EKG findings
100
Describe the etiology of an anterior fascicular block
101
Describe the EKG for anterior fascicular block
102
Describe the etiology of posterior fascicular block
R axis deviation associated with MI, S1Q3
103
Describe the etiology of a bifascicular block
104
describe the etiology of atrial septal defect
105
describe the clinical presentation of atrial septal defect
106
Describe the murmur & diagnostic testing for atrial septal defect
107
Describe the etiology of patent foramen ovale
108
Describe the etiology of ventricular septal defect
Acyanotic Common, Communication between ventricles (single or multi), shunting L to R Location class - peri/membranous - muscular defects - outlet defects (subpulmonic) - inlet defects (AV canal)
109
Describe the clinical presentation of ventricular septal defect
Symptoms depend on size & pressure differentials Causes pulmonary HTN if L to R is extreme (Eisenmenger syndrome)
110
Describe the murmur and diagnostic testing for VSD
Murmur: small 2-3/6 harsh, blowing, holosystolic, heard best at LLSB, sometimes 4/6 thrill, small defects result in louder murmur, larger can be absent or 1-2/6 EKG may see LVH because of increased workload CXR - normal or CHF and L hypertrophy
111
Describe the etiology of patent ductus arteriosus
112
Describe the clinical presentation of patent ductus arteriosus
113
Describe the murmur and diagnostic testing for patent ductus arteriosus
114
Describe the treatment for patent ductus arteriosus
115
Describe the etiology for coarctation of the aorta
116
Describe the clinical presentation for coarctation of the aorta
117
Describe the murmur and diagnostic testing for coarctation of the aorta
118
Describe the treatment for coarctation of the aorta
119
Describe the etiology of truncus arteriosus
120
Describe the murmur and diagnostic testing for truncus arteriosus
121
Describe the etiology of hypoplastic left heart syndrome
122
Describe the etiology of tetralogy of fallot
123
Describe the clinical presentation for tetralogy of fallot
124
Describe the murmur and diagnostic testing for tetralogy of fallot
125
Describe the etiology for total anomalous pulmonary venous return
126
Describe the diagnostic testing for total anomalous pulmonary venous return
echo
127
Describe the etiology for transposition of great vessels
128
Describe the diagnostic testing for transposition of the great vessels
129
Describe the treatment for transposition of the great vessels
130
Describe the types of heart failure
131
Describe the clinical presentation of heart failure
132
Describe the physical exam of heart failure
133
Describe the diagnostic testing for heart failure
134
Describe which medications to avoid in heart failure
135
Describe the treatment for acute decompensated heart failure
136
Describe the etiology of cor pulmonale
137
Describe the clinical presentation of cor pulmonale
138
Describe the diagnostic testing for cor pulmonale
139
Describe the treatment for cor pulmonale
140
Describe the etiology of atrial fibrillation
141
Describe the clinical presentation of the types of atrial fibrillation
142
Describe the diagnostic testing for atrial fibrillation
143
Describe the treatment for atrial fibrillation
144
Describe the causes and RFs for atrial fibrillation
145
Describe the etiology and risk factors for metabolic syndrome
146
Describe the clinical presentation of metabolic syndrome
147
Describe the treatment for dyslipidemia
148
Describe the treatment for elevated LDL
cholesterol absorption inhibitor (ezetimibe 10mg QD)
149
Describe the treatment for high triglycerides
150
Describe the etiology & clinical presentation of stable angina
reversible ischemia
151
Describe the diagnostic testing for stable angina
152
Describe the treatment for stable angina
153
Describe the etiology of unstable angina
154
Describe the clinical presentation of unstable angina
155
Describe the diagnostic testing for unstable angia
156
describe the treatment for unstable angina
157
Describe the etiology of PAD
158
Describe the clinical presentation of PAD
159
Describe the PE & diagnostic testing for PAD
160
Describe the treatment for PAD
161
Describe the etiology of critical limb ischemia
Can be a presentation of PAD pts Significant ischemia that threatens the limb, insufficient arterial flow d/t thrombosis of atherosclerotic artery
162
Describe the clinical presentation of critical limb ischemia
Pain, paresthesia, pallor, paralysis, pulselessness, poikilothermia (cold) Rest pain, ischemic ulceration, gangrene
163
Describe the treatment for critical limb ischemia
Catheter directed thrombolysis or surgical revascularization if limb is salvageable Amputation if limb is not salvageable
164
Describe the etiology of venous thromboembolism
165
Describe the clinical presentation of VTE
166
Describe the diagnostic testing for VTE
167
Describe the treatment for VTE
168
Describe the etiology of buerger's disease
169
Describe the clinical presentation of buerger's disease
170
Describe the treatment for buerger's disease
171
Describe the etiology of varicose veins
172
Describe the treatment for varicose veins
173
Describe the etiology of superficial thrombophlebitis
174
Describe the etiology of chronic venous insufficiency
175
Describe the clinical presentation of chronic venous insufficiency
176
Describe the treatment for chronic venous insufficiency
177
Describe the difference between venous & arterial insufficiency
178
Describe the etiology of acute infectious pericarditis
Usually initially diagnosed as non-specific chest pain Infectious - viral: coxsackie, EBV, HCV, HIV, parvo B19, covid - Bacterial: pneumo, meningo, gono, staph, strep, coxiella (major concern for TB) - rare fungal & parasitic
179
Describe the etiology of non-infectious pericarditis
Non-infectious - pericardial injury syndromes (post-MI, trauma) - systemic: SLE, RA, sjogren’s - malignancy (MC lung, breast, lymphoma) - metabolic: uremia, hypothyroidism - traumatic: penetrating or radiation injury (chemo, cardiac meds, isoniazid, phenytoin, PCNs)
180
Describe the clinical presentation & PE for acute pericarditis
181
Describe the diagnostic testing for acute pericarditis
Chest pain workup CXR: typically normal or evidence of effusion CBC & Inflammatory markers: leukocytosis, elevated CRP, ESR Troponin not elevated Consider D-dimer Echo: usually normal unless large effusion EKG: classically diffuse ST elevation or PR segment depression (except in aVR & V1 - ST depression), may have no ST changes but have diffuse T wave inversion
182
Describe the diagnostic criteria for acute pericarditis
183
Describe the treatment for acute pericarditis
184
Describe the etiology of constrictive pericarditis
185
Describe the clinical presentation & diagnostic testing for constrictive pericarditis
186
Describe the treatment for constrictive pericarditis
187
Describe the etiology of pericardial effusion
188
Describe the clinical presentation of pericardial effusion
189
Describe the diagnostic testing for pericardial effusion
190
Describe the treatment for pericardial effusion
191
Describe the etiology for cardiac tamponade
192
Describe the clinical presentation of cardiac tamponade
193
Describe the diagnostic testing for cardiac tamponade
194
Describe the treatment for cardiac tamponade
195
Define pulsus paradoxus
196
Describe the etiology of myocarditis
197
Describe the clinical presentation of myocarditis
198
Describe the diagnostic testing for myocarditis
199
Describe the treatment for myocarditis
200
Describe the etiology of infective endocarditis
Inflammation of endocardium (can lead to regurgitation) Vegetations on valves/devices - microorganisms, fibrin, platelets, inflammatory cells, granulomas Non-infectious is rare (malignancy, hypercoagulable states - can cause embolic stroke) Causes: rheumatic valvular disease (mitral MC), congenital, MVP, IVDU (tricuspid MC) MC: staph aureus, epidermidis, viridans (rare oral flora HACEK)
201
Describe the clinical presentation of infective endocarditis
Fever, chills in 90%, malaise, myalgia, arthralgia, constitutional sxs, highly variable Acute: sudden onset within a week Subacute: slower onset (4 weeks) HF from valvular insufficiency, renal impairment, metastatic infection (osteomyelitis, organ abscess, septic arthritis), systemic embolization
202
Describe the diagnostic testing/PE for infective endocarditis
Murmur: new or worsening, 85%, regurgitant Splenomegaly, petechiae, splinter hemorrhages of fingernails, janeway lesions (painless, flat red macule son palms/soles, last longer than Osler), Osler nodes (tender, erythematous nodules on palms/soles/digits), Roth spots (pale retinal patch surrounded by darker ring of hemorrhage from inflammation of small arteries) Blood cultures before abx (3 samples from different sites), echo will show vegetations (TEE better) Duke Criteria (2 major, 1 major & 3 minor, or 5 minor)
203
Describe the treatment for infective endocarditis
Inpatient, ABCs IV abx (4-6 weeks) Remove devices if indicated +/- surgical debridement if refractory to abx, valve replacement Repeat blood cultures until negative for 1-2 days in a row IV fluid resuscitation, antipyretics, empiric anticoag NOT recommended dt risk of ICH Prophylactic abx prior to dental procedures w/ hx of endocarditis
204
Describe the etiology of dilated cardiomyopathy
205
Describe the clinical presentation of dilated cardiomyopathy
206
Describe the diagnostic testing & murmur for dilated cardiomyopathy
207
Describe the treatment for dilated cardiomyopathy
208
Describe the etiology of restrictive cardiomyopathy
209
Describe the clinical presentation of restrictive cardiomyopathy
210
Describe the diagnostic testing/heart sounds for restrictive cardiomyopathy
211
Describe the treatment for restrictive cardiomyopathy
212
Describe the etiology of amyloidosis
213
Describe the clinical presentation of amyloidosis
214
Describe the diagnostic testing for amyloidosis
215
Describe the etiology of hypertrophic cardiomyopathy
Diastolic failure Heart muscle becomes bulky, large, and impairs adequate pumping leading to fatal arrhythmias Historical indicators: low exercise tolerance, SOB with exertion, dizziness with exercise, fatigue, hx syncope with exercise RF: genetic (autosomal dom) Patho: physiologic response or inherited inability for cardiac muscle to contract properly, ventricular spaces shrink, SV/CO reduced - intermittent outflow obstruction can develop obstructing mitral valve
216
Describe the clinical presentation of hypertrophic cardiomyopathy
217
Describe the murmur & diagnostic testing for hypertrophic cardiomyopathy
Auscultate sitting, lying, valsalva - high pitched crescendo-decrescendo midsystolic ejection murmur at LLSB exacerbated with valsalva, S4 Echo: gold standard, shows septal thickness, LV wall thickness > 1.3 Confirmatory tests: genetic testing, cardiac biopsy will show myofibril disarray (not parallel)
218
Describe the treatment for hypertrophic cardiomyopathy
219
Identify the leads where Q waves/ST elevation will be seen for the following areas of infarction & associated arteries
220
Identify the valvular dysfunctions/causes of the following systolic/diastolic murmurs
221
Describe the etiology/RF for RBBB
222
Describe the clinical presentation for RBBB
223
Describe the EKG for a RBBB
224
Describe the etiology/RF for a LBBB
225
Describe the clinical presentation of a LBBB
226
Describe the EKG for a LBBB
227
Describe the treatment for a RBBB & LBBB
treat underlying condition, pace if symptomatic
228
Describe the etiology for a left anterior fascicular block
229
Describe the EKG for a left anterior fascicular block
230
Describe the etiology of a left posterior fascicular block
231
Describe the EKG for a left posterior fascicular block
232
Describe the etiology of sick sinus syndrome
233
Describe the clinical presentation of sick sinus syndrome
234
Describe the EKG findings in sick sinus syndrome
235
Describe the treatment for sick sinus syndrome
treat underlying condition or pace
236
Describe the etiology of cardiogenic shock
237
Describe the clinical presentation of cardiogenic shock
238
Describe the diagnostic testing for cardiogenic shock
239
Describe the treatment for cardiogenic shock
240
Describe the most common cause of cardiogenic shock
241
Describe some of the mechanical circulatory supports for cardiogenic shock treatment
- intra-aortic balloon pump - impella device - VA-ECMO (veno-arterial extracorporeal membranous oxygenation) - LVAD (left ventricular assist device - HeartMate3)
242
Describe how an intra-aortic balloon pump works for cardiogenic shock
- short term support following MI - balloon inserted via femoral artery & synced to EKG - inflates during diastole to back-fill the coronary arteries - deflates during systole to suction blood forward
243
Describe how an impella device works in cardiogenic shock
- percutaneous ventricular assist device - increases blood flow in line with aortic circulation via femoral artery into left ventricle - encourages continuous forward flow (like a jetski motor) - risk of hemolytic anemia
244
Describe how VA-ECMO treats cardiogenic shock
- temporary cardiopulmonary bypass via femoral vein & artery - deoxygenated blood is pulled from the right atrium, passes through gas exchange membrane, and is injected into iliac artery - allows adequate tissue perfusion while greatly reducing cardiac preload/afterload
245
Describe how an LVAD treats cardiogenic shock
- surgically inserted impellor - blood pulled froom apex of LV, spun through impellor, injected into aortic root - continuous flow support - numerous complications (infection, suction events, thrombus, hemolytic anemia, battery failure)